Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PBT
4676
Permian Basin Royalty Trust
PBT
$1.52B
| $880K | ﹤0.01% |
99,259
+46,906
| +90% | +$430K |
|
4677
PUT
PetMed Express
PETS
$39.5M
| $878K | ﹤0.01% |
19,300
+6,700
| +53% | +$264K |
|
|
HOLX
4678
PUT
DELISTED
Hologic
HOLX
| $876K | ﹤0.01% |
20,500
+2,600
| +15% | +$104K |
|
4679
CALL
Planet Fitness
PLNT
$3.8B
| $876K | ﹤0.01% |
25,300
-1,200
| -5% | -$35.5K |
|
4680
Mativ Holdings
MATV
$674M
| $875K | ﹤0.01% |
19,301
-6,840
| -26% | -$297K |
|
|
VIVO
4681
DELISTED
Meridian Bioscience Inc
VIVO
| $875K | ﹤0.01% |
62,515
-66,364
| -51% | -$971K |
|
|
AIMT
4682
DELISTED
Aimmune Therapeutics
AIMT
| $875K | ﹤0.01% |
23,133
-536,508
| -96% | -$17.3M |
|
|
LM
4683
PUT
DELISTED
Legg Mason, Inc.
LM
| $873K | ﹤0.01% |
20,800
-10,600
| -34% | -$416K |
|
|
TECD
4684
CALL
DELISTED
Tech Data Corp
TECD
| $872K | ﹤0.01% |
8,900
-15,700
| -64% | -$1.47M |
|
4685
Helix Energy Solutions
HLX
$1.54B
| $871K | ﹤0.01% |
115,550
-620,404
| -84% | -$4.39M |
|
|
SGG
4686
CALL
DELISTED
iPath Bloomberg Sugar Subindex Total Return ETN due June 24, 2038
SGG
| $871K | ﹤0.01% |
28,200
+7,400
| +36% | +$219K |
|
4687
CALL
Alkermes
ALKS
$8.23B
| $870K | ﹤0.01% |
15,900
+11,500
| +261% | +$587K |
|
4688
CALL
A.O. Smith
AOS
$8.45B
| $870K | ﹤0.01% |
14,200
-4,200
| -23% | -$255K |
|
4689
CALL
ProShares Ultra Bloomberg Natural Gas
BOIL
$397M
| $870K | ﹤0.01% |
13
+7
| +117% | +$513K |
|
4690
CALL
Dell
DELL
$317B
| $870K | ﹤0.01% |
38,127
-111,529
| -75% | -$2.53M |
|
4691
CALL
ProShares Ultra Semiconductors
USD
$2.96B
| $870K | ﹤0.01% |
340,800
+100,800
| +42% | +$254K |
|
4692
PUT
Agios Pharmaceuticals
AGIO
$2B
| $869K | ﹤0.01% |
15,200
+5,600
| +58% | +$352K |
|
4693
PUT
Banc of California
BANC
$3.13B
| $869K | ﹤0.01% |
42,100
+2,100
| +5% | +$43.9K |
|
4694
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.6B
| $869K | ﹤0.01% |
+7,786
| New | +$843K |
|
4695
iShares International Equity Factor ETF
INTF
$3.77B
| $868K | ﹤0.01% |
30,093
-100,893
| -77% | -$2.87M |
|
|
ATCO
4696
DELISTED
Atlas Corp.
ATCO
| $868K | ﹤0.01% |
128,660
+104,791
| +439% | +$684K |
|
4697
CALL
AllianceBernstein
AB
$3.41B
| $867K | ﹤0.01% |
34,600
+8,200
| +31% | +$207K |
|
4698
United Fire Group
UFCS
$1.4B
| $867K | ﹤0.01% |
19,026
-1,692
| -8% | -$79.1K |
|
4699
Golub Capital BDC
GBDC
$3.44B
| $866K | ﹤0.01% |
+48,579
| New | +$899K |
|
4700
PUT
Penske Automotive Group
PAG
$14.4B
| $866K | ﹤0.01% |
18,100
+9,200
| +103% | +$433K |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.